tm
Seeing Is Believing
tm
Seeing Is Believing
CERE is currently covered by 6 analysts with an average potential upside of $9.45 (35.1%) from yesterday's end of day stock price of $41.25. Cerevel Therapeutics Holdings activity chart has currently 7 price targets and 24 ratings on display.
Analysts average stock forecasts to be materialized ratio is 54% with an average time for these price targets to be met of 96.7 days.
Highest price target for CERE is $41, Lowest price target is $21, average price target is $31.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 07-Dec-2023. First documented stock forecast 10-Dec-2020.
Currently, out of the existing stock ratings of CERE - 12 which are a Hold (60%), 8 which are a Buy (40%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
45
$3.75 (9.09%)
46
3 days ago
1/3 (33.33%)
$3.89 (9.46%)
434
Hold
25
$-16.25 (-39.39%)
29
4 months 3 days ago
8/8 (100%)
$4.45 (21.65%)
67
Buy
42
$20.17 (92.40%)
40
4 months 7 days ago
2/5 (40%)
$13.08 (57.19%)
28
Buy
41
$19.17 (87.81%)
45
4 months 7 days ago
0/5 (0%)
$19.34 (73.84%)
Hold
30
$-11.25 (-27.27%)
28
6 months 17 days ago
3/3 (100%)
$-3.27 (-9.83%)
22
What is CERE (Cerevel Therapeutics Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on CERE (Cerevel Therapeutics Holdings) with a proven track record?
Which analyst has the most public recommendations on CERE (Cerevel Therapeutics Holdings)?
Which analyst is the currently most bullish on CERE (Cerevel Therapeutics Holdings)?
Which analyst is the currently most reserved on CERE (Cerevel Therapeutics Holdings)?
